OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

“…After 4 weeks, when the tumor size was approximately 100 mm³ (T₀) mice were treated with OCA (0.03% w/w, 30 mg/kg) alone or combined with Cisplatin (2.4 mg/Kg in 100 μl) or Gemcitabine (1.05 mg/Kg in 100 μl) for 5 additional weeks. a) Results are expressed as percent increase in tumor volume at different time points. …”

The ratio of standard deviation to mean dose (SD/mean) decreases with neuronal dose. by Murat Alp (781371)

Decreased biomechanical stability of bones from <i>Col1a1-Krm2</i> transgenic mice. by Jochen Schulze (365258)

“…(C) µCT scanning of the femora showing reduced cortical thickness and impaired mineralization (scale bars, 500 µm). (D) Cortical thickness (C.Th.) and bone mineral density (vBMD) are decreased in <i>Col1a1-Krm2</i> transgenic mice compared to wildtype littermates. …”

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”

Retigabine and ML213 decrease the constriction tone of human detrusor strips. by Julie Svalø (693320)

“…<p>(A) The original DSM tension recordings illustrate the relaxatory effect of retigabine and ML213, which are K_v7.2–7.5 and K_v7.2/7.4/7.5 channel activators, respectively. …”

Decreased function of Nrf2 in the aging heart. by Sellamuthu S. Gounder (306106)

“…<p>(<b>A</b>) <b>Decreased nuclear translocation of Nrf2 is evident in the heart of aging mice.…”

Dominant negative Hif-2α decreases bacterial burden via an iNOS dependent mechanism. by Philip M. Elks (324793)

HEWL interacts with dissipated oleic acid micelles, and decreases oleic acid cytotoxicity - Fig 2 by Qin Huang (49441)

Subjects:

Decreased epithelial PGR expression in <i>Arid1a</i>^<i>d/d</i> mice. by Tae Hoon Kim (128536)

AMPKα activation with FND-4b decreased proliferation of breast cancer cells with similar efficacy to AICAR. by Jeremy Johnson (535080)

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

Retinoschisin secretion into the conditioned medium is decreased by addition of cytochalasin D. by Eiko Kitamura (349087)

“…(D) Retinoschisin secretion decreases in a dose-dependent manner by treatment of cells with cytochalasin D at concentrations between 0.5 µM and 2 µM. …”

YTX treatment decreases tumour development in the B16F10 melanoma mouse model. by Araceli Tobío (3545306)

NDRG2 is decreased during LX-2 activation. by Jiandong Yang (196004)

AA-deficient <i>sfx</i> mice had decreased articular cartilage. by Richard C. Lindsey (7148168)

Activation of NMDA receptors with D-serine obviously limited the decrease of p-CREB in the hippocampus of the surviving LPS-treated mice. by Shuibing Zhang (4336402)

Cytochalasin D decreases pyroptosis in TLR ligand-activated Raw264.7 cells. by Peeraya Ekchariyawat (3911113)

A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization-6 by Chandrashekhar D Kamat (60176)

“…</p><p></p>nce or absence of 5 μM of the HIF inhibitor YC-1, or 62.5 μM α-lipoic acid (ALA), or 25–100 PFU/cell UCP2 adenovirus, or 10 μM apocynin (APO), or 10 μM oxypurinol (OXY) or to 1 mM L-NAME. …”

PIKfyve inhibition results in decreased melanin accumulation and decreased accumulation of advanced stage melanosomes. by Marc C. Liggins (5018390)

Sepsis decreases the frequencies of CD4 T cells. by Mian Zhou (339595)